Skip to main content
. 2014 Aug 4;4(2):12. doi: 10.7603/s40681-014-0012-3

Table 4.

End-point plasma glucose control, inflammatory markers, hepatic lipids, and oxidative enzyme activities.

N HFD RN 1 × AP 2 × AP
FBS (mg/dL) 139.0 ± 7.1b 171.3 ± 5.6a 161.6 ± 8.2a 141.0 ± 2.1b 133.6 ± 7.4b
Insulin (μg/L) 0.21 ± 0.04b 1.20 ± 0.25a 0.38 ± 0.20b 0.29 ± 0.07b 0.22 ± 0.04b
HOMA-IR 1.7 ± 0.4b 7.9 ± 2.4a 4.2 ± 2.5ab 2.5 ± 0.6b 1.9 ± 0.4b
Vit E (μg/mL) 20.8 ± 1.0a 15.8 ± 0.7b 17.7 ± 1.2ab 20.0 ± 1.7a 21.2 ± 1.9a
Vit C (μM) 453.9 ±8.0bc 388.3 ± 12.7d 414.0 ± 17.0cd 476.4 ± 27.4ab 532.9 ± 37.5a
TNF-α (ng/mL) 1.8 ± 0.0bc 3.2 ± 0.4a 2.7 ± 0.5ab 1.2 ± 0.2c 1.2 ± 0.2c
IL-6 (ng/mL) 21.2 ± 2.2b 48.8 ± 5.8a 34.8 ± 7.2ab 25.1 ± 3.2b 23.0 ± 2.8b
Hepatic lipids
cholesterol (mg/g) 2.7 ± 0.2c 28.7 ± 3.5a 12.0 ± 2.6b 4.9 ± 1.1c 5.5 ± 1.8c
triglyceride (mg/g) 4.5 ± 0.2c 19.1 ± 1.4a 8.8 ± 0.6b 8.4 ± 0.9b 6.4 ± 0.8bc
Hepatic oxidative status
SOD (U/mg) 210.0 ± 12.0a 142.2 ± 11.9b 187.3 ±11.0ab 172.9 ± 32.8ab 206.1 ± 34.2a
GR (nmol/min/mg) 20.2 ± 3.3a 10.9 ± 1.2b 12.5 ± 2.1ab 14.9 ± 2.4ab 19.8 ± 3.5a
Catalase (nmol/min/mg) 2032.6 ±384.1b 3111.8 ± 250.2a 1664.0 ± 173.2b 1545.6 ± 166.4b 1804.4 ±162.4b
GPX (nmol/min/mg) 605.8 ± 85.5a 351.9 ± 16.0c 344.9 ± 23.4c 398.7 ± 14.7bc 511.8 ± 46.7ab
Vit E (μg/g) 63.4 ± 7.8a 14.1 ± 2.0d 18.8 ± 2.2cd 29.8 ± 3.4bc 34.2 ± 3.1b
MDA (μmol/g) 687.3 ± 62.2c 1433.5 ± 59.8a 933.7 ± 43.6b 740.1 ± 45.9c 699.6 ± 58.1c

Data presented as mean ± SEM.

Superscripts represent statistically significant differences among groups. p <0.05 N, normal dietary group; HFD, high-fat diet group; RN, normal diet reversion group; 1× and 2× AP, normal diet recovery supplemented with 0.75% (w/w) and 1.5% (w/w) of Auricularia polytricha water extract, respectively.FBS, fasting blood sugar; HOMA-IR, homeostatic model assessment- insulin resistance; TNF, tumor necrosis factor; IL, interleukin; SOD, superoxide dismutase; GR, glutathione reductase; GPx, glutathione peroxidase; MDA, malondialdehyde.